Cerebellum’s KEMET Corporation KEM Stock Holding History

Cerebellum’s Portfolio KEM Stock Details KEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-9,264	Closed	-$172K	–	589
2018 Q3	$172K	Buy	+9,264	New	+$228K	0.27%	280

Other funds holding KEM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cerebellum's KEM Position: Q4 2018 in Review

Cerebellum sold out of KEMET Corporation (KEM) in Q4 2018, closing a stake of 9,264 shares — an estimated $172K sold.

Cerebellum first reported a position in KEM in Q3 2018 and held it in 1 quarter. The position peaked at $172K in Q3 2018. 215 funds tracked by Wall St. Rank hold KEM as of Q4 2018.

Cerebellum reported no remaining KEMET Corporation position as of Q4 2018 after selling out during the quarter.
Cerebellum sold 9,264 KEMET Corporation shares in Q4 2018, an estimated $172K.
Cerebellum first reported a position in KEMET Corporation in Q3 2018 and held it in 1 quarter.
Cerebellum's KEMET Corporation position peaked at $172K in Q3 2018.
215 funds tracked by Wall St. Rank held KEMET Corporation as of Q4 2018.

Based on Cerebellum's 13F filing for Q4 2018, filed 10 Jan 2019.